Innovations in biotechnology have had a significant influence on health care outcomes but often at increased costs. The new challenges facing the US health care system call for low-cost, affordable innovative solutions in delivery of services to achieve the triple aim: improving the experience of care, improving population health, and reducing the per capita costs of health care.
One such innovative approach is self-administered outpatient intravenous antibiotic treatment (OPAT). In this approach, patients who need intravenous antibiotics for up to 8 weeks are taught to self-administer antibiotics at home. The traditional treatment approach for these patients in the United States involves 1 of the following: supervised administration of intravenous antibiotics at an infusion center, administration at a skilled nursing facility, or administration at home with nursing assistance. These options represent the usual forms of OPAT.
Bhavan KP, Agrawal D, Cerise F. Achieving the Triple Aim Through Disruptive Innovations in Self-care. JAMA. 2016;316(20):2081–2082. doi:10.1001/jama.2016.15391
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: